MAN2A1-FER, a fusion gene encoding for a tyrosine protein kinase, was present in 82.3% (121/147) blood samples from the prostate cancer patients, representing the most frequent fusion transcript detected in the blood of prostate cancer patients. This evidence concerns the gene FER and prostate carcinoma.